永輝超市(601933.SH):選舉張軒鬆擔任董事長、聘任李國為首席執行官
格隆匯3月6日丨永輝超市(601933.SH)公佈,公司第四屆董事會第十七次會議召開,審議通過關於選舉永輝超市股份有限公司第四屆董事會董事長的議案,經徵求各位董事意見,一致提名張軒鬆擔任公司第四屆董事會董事長,任期與本屆董事會一致。
亦審議通過關於聘任永輝超市股份有限公司首席執行官的議案,與會董事一致同意,擬聘任李國為公司首席執行官(CEO);任期與本屆董事會一致。
審議通過關於聘任永輝超市股份有限公司首席財務官的議案,經李國提名,與會董事一致同意,擬聘任吳莉敏為公司首席財務官(CFO);任期與本屆董事會一致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.